Custom Pharmaceutical Formulation Development
From concept to a tech-transfer-ready formulation, with the data to back it.
Vsolv Research develops custom formulations for pharmaceutical, nutraceutical and cosmetic companies, startups and research groups. We take a product from target profile through pre-formulation, prototype development, DoE optimisation and stability planning to a technology-transfer package. Commercial manufacture is carried out by licensed partners.
Who it is for
- Startups developing their first product
- MSMEs expanding a portfolio or reformulating
- Pharma companies needing extra development capacity
- Academic groups translating novel delivery systems
Dosage forms
- Oral solids: tablets, capsules, granules, orally disintegrating and modified-release forms
- Topicals: gels, creams, ointments, emulgels
- Oral liquids: solutions, suspensions, syrups
- Novel delivery: nanoparticles, liposomes, solid lipid nanoparticles, microemulsions, in-situ gels
- Nutraceutical and cosmetic formats
What you receive
- Quality target product profile (QTPP) and critical quality attributes
- Pre-formulation and excipient compatibility report
- Prototype formulations with batch records
- DoE optimisation and design space, documented in QbD Risk Navigator
- Analytical and in-vitro evaluation: assay, release or dissolution, physical tests, carried out at our partner laboratories
- Stability study protocol per ICH Q1A(R2)
- Technology-transfer dossier: final formula, process, specifications and critical parameters
How the work runs
- Brief and NDA.
- Feasibility and target profile.
- Pre-formulation.
- Prototypes.
- Optimisation.
- Stability planning and technology transfer.
How fees are decided
Your fee depends on: dosage form and complexity · API availability and properties · number of strengths or variants · analytical work required · stability duration · IP arrangement.
You receive a written scope, agreed timeline and quote within 2 working days of your consultation.
Scope and limits
Development and trial batches are made under the required licences. Commercial manufacture is carried out by licensed partners. Product registration is the sponsor’s responsibility, supported by our development data.
Frequently asked questions
Who owns the formulation IP?
On full payment, the client owns the final formulation and development data, as set out in the contract. We sign an NDA before any technical discussion.
Do you manufacture commercial batches?
No. We develop and transfer the technology, and licensed manufacturing partners produce commercial batches. We can support the technology transfer at the manufacturing site.
How long does it take to get a prototype?
It depends on the dosage form and the API. Conventional dosage forms are quicker than novel delivery systems. We agree the timeline in your written quote.
Can you reformulate an existing product?
Yes. We can improve stability, taste, release profile, cost or excipient choice, or develop a new strength or dosage form.
Do you work on nutraceutical and cosmetic products?
Yes, following FSSAI or Cosmetics Rules 2020 requirements as applicable.
Last reviewed 27 September 2026.